Last $51.46 USD
Change Today +0.11 / 0.21%
Volume 418.1K
DXCM On Other Exchanges
Symbol
Exchange
DXCM is not on other exchanges.
As of 5:10 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Andrew K. Balo

Senior Vice President of Clinical & Regulatory Affairs, DexCom, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

66--

Background*

Mr. Andrew K. Balo, also known as Andy, serves as Vice President of Regulatory and Clinical Affairs at Post-Hypothermia Corporation. Mr. Balo has been Senior Vice President of Clinical & Regulatory Affairs at Dexcom, Inc. since March 2008. He oversees all of Dexcom's clinical trials, statistical analyses, and regulatory submissions. He is an industry expert in regulatory strategies and sits on several FDA panels including cardiovascular, neurological and gastrointestinal ...

Read Full Background

Corporate Headquarters*

6340 Sequence Drive
San Diego, California 92121

United States

Phone: 858-200-0200
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
University of Maryland
Unknown/Other Education
University of California-Los Angeles
Unknown/Other Education
The Leland Stanford Junior University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DXCM:US $51.46 USD +0.11

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Justin C. Dearborn Chief Executive Officer, President, Corporate Secretary, Director, Member of Executive Committee and Chief Executive Officer of Merge DNA
Merge Healthcare Incorporated
$347.5K
Eyal Shalom Chief Executive Officer
RadView Software Ltd.
--
Lisa A. Hook Chief Executive Officer, President, Director and Member of Neutrality Committee
NeuStar, Inc.
$698.0K
Patrick J. Sullivan Chief Executive Officer, President and Director
Insulet Corporation
--
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
$472.1K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DEXCOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.